Welcome to our dedicated page for Globe Life SEC filings (Ticker: GL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Globe Life Inc. (NYSE: GL) filings with the U.S. Securities and Exchange Commission, along with AI-generated explanations to help interpret key disclosures. Globe Life is an insurance holding company focused on life and supplemental health insurance, annuities and related investment activities, and its SEC filings offer detailed insight into these operations.
Investors can review current reports on Form 8-K, where Globe Life reports material events such as quarterly earnings releases, changes to executive retirement or compensation plans and significant financing arrangements. For example, recent 8-K filings describe the company’s second and third quarter financial results, an amendment to the Supplemental Executive Retirement Plan and the creation of a pre-capitalized trust securities (P-CAP) program that provides contingent liquidity through senior notes.
Filings also document corporate governance and executive arrangements, including early retirement reduction factors and vesting rules under the SERP in connection with change-of-control protection periods. These disclosures help clarify how Globe Life structures retirement benefits and severance protections for certain executives.
Through this page, users can track debt and capital structure–related disclosures, such as facility agreements, trust arrangements and obligations tied to senior notes and pre-capitalized trust securities. These items illustrate how Globe Life manages liquidity and long-term financing in support of its insurance and investment activities.
The platform supplements raw filings with AI-powered summaries that highlight important sections, explain technical terms and distinguish between GAAP and non-GAAP measures when referenced in attached earnings materials. Real-time updates from EDGAR ensure that new 8-Ks and other forms appear promptly, while structured data views make it easier to locate information related to executive plans, financing arrangements and reported results.
Dolores L. Skarjune, Executive Vice President and Chief Administrative Officer of Globe Life Inc. (GL), reported multiple transactions dated 09/10/2025. She exercised an employee stock option to acquire 6,200 shares at an exercise price of $103.23 per share. On the same date she sold 3,354 shares at prices ranging from $139.31 to $140.01 and sold an additional 1,620 shares at prices ranging from $140.015 to $140.49. After these transactions she beneficially owned 11,037 shares directly and 2,701.527 shares indirectly through a 401(k) plan. The Form 4 was signed by an attorney-in-fact on 09/11/2025.
Globe Life Inc. Form 144 filing for proposed sale of common stock. The notice reports an intended sale of 6,200 shares of Globe Life common stock through APEX CLEARING on the NYSE with an aggregate market value of $870,852 and approximately 80,432,773 shares outstanding. The shares were acquired on 02/23/2022 via a stock option exercise from Globe Life Inc., and the proposed sale date is 09/10/2025. The filer states there were no sales by the same person in the past three months and includes the standard representation that they are not aware of any undisclosed material adverse information about the issuer.
This Form 3 reports that Robert Sweeney, listed at the provided McKinney, TX address, filed an initial beneficial ownership statement for Globe Life Inc. (GL) related to a 07/28/2025 event. Mr. Sweeney is identified as an officer (EVP, Underwriting & Sales Adm.). The filing discloses zero shares of Globe Life common stock held directly or indirectly and references a 401(k) plan. The form is signed by an attorney-in-fact on behalf of Robert Sweeney.
Globe Life Inc. submitted a Form 13F reporting its institutional holdings. The report lists 2 holdings with a total market value of $365,007,875 as reported on the cover page. The filing was signed by Christopher T. Moore and bears an 08-08-2025 signature date.
Globe Life Inc. (GL) filed its Q2-25 Form 10-Q. Total assets rose 2.5% since YE-24 to $29.8 bn, driven by a $353 mm increase in invested assets to $19.9 bn and a $259 mm build in deferred acquisition costs. Shareholders’ equity improved to $5.42 bn from $5.31 bn as retained earnings increased $451 mm to $8.45 bn, partially offset by additional share repurchases (treasury stock up $394 mm, 16.2 mm shares held).
Policy liabilities grew 2.2% to $20.14 bn, with future policy benefits accounting for $18.85 bn. Debt remained essentially flat at $2.79 bn (short- and long-term combined), while the company’s cash position strengthened to $239 mm versus $165 mm at YE-24.
On the income side, premium revenue advanced 4.3% YoY to $1.22 bn for the quarter and 4.5% to $2.42 bn year-to-date. Net investment income ticked down 1.2% to $282 mm, and realized losses widened to $18.6 mm versus $12.6 mm a year earlier. Further earnings data were not provided in the excerpt. Common shares outstanding on 31 Jul 25 were 81.0 mm.
Globe Life Inc. (GL) – Form 4 insider activity
On 08/01/2025, EVP & Chief Strategy Officer Michael C. Majors exercised 10,000 employee stock options at an exercise price of $100.74. The newly issued shares were almost entirely sold the same day:
- Sales of 9,991 and 9 shares occurred within a $136.79–$137.78 range; weighted average disclosed at $137.41.
- Approximate gross proceeds: $1.37 million; option cost: $1.01 million.
- After the transactions, Majors holds 47,066 common shares directly, unchanged versus pre-exercise level.
- He retains 27,000 stock options (right to buy) expiring 02/26/2027.
No other equity or derivative movements were reported. The filing reflects a routine option exercise-and-sell transaction rather than an outright open-market purchase or disposal.
Globe Life Inc. (GL) – Form 4, filed 31-Jul-2025
Senior Vice-President & Chief Accounting Officer Michael Shane Henrie reported an option exercise and related sale on 29-Jul-2025:
- Option exercise (Code M): 3,250 shares at a $103.23 strike (grant dated 23-Feb-2025, expiry 23-Feb-2029).
- Open-market sale (Code S): 3,250 shares sold at a volume-weighted average price of $139.7526 (individual prices $139.67–$139.90).
Net effect on ownership
- Direct common stock declined from 6,290 to 3,040 shares (-3,250 shares).
- Indirect holdings remain 152.182 shares in the 401(k) plan.
- No remaining derivative securities from the exercised grant.
The transaction generated a spread of $36.52 per share between exercise price and sale price, indicating a gross pre-tax gain of roughly $0.12 million. Henrie continues to hold approximately 3.2 k direct shares plus 152 plan shares.